DPP-4 inhibitors × glycemic control

TrialDiabetes care2013

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.

Guntram Schernthaner et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 755 people · 2013

Not counted

Probably lowered glycemic control

−0.37percentage points−0.50 to −0.25

As reported

difference −0.37 %, 95% CI −0.50 to −0.25

One number in the abstract

the abstract, start to end

squares mean difference between groups, -0.37% [95% CI, -0.50 to -0.25] or

← favours treatmentfavours comparator →
could be chance
Glycemic control
−0.37−0.50 to −0.25
SGLT2 inhibitorsDPP-4 inhibitorsGlycemic control
1 / 3

205 papers cite itlatest 60 shown

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 23564919